Skip to main content
Mukka Proteins Limited logo

Mukka Proteins Limited — Investor Relations & Filings

Ticker · MUKKA ISIN · INE0CG401037 LEI · 3358001F6BWKSFSZ2U02 BSE.NS Manufacturing
Open in API
Filings indexed 220 across all filing types
Latest filing 2024-10-24 Proxy Solicitation & In…
Country IN India
Listing BSE.NS MUKKA

About Mukka Proteins Limited

https://mukkaproteins.com/

Mukka Proteins Limited specializes in the manufacture and supply of high-quality fish meal, fish oil, and fish soluble paste. The company serves as a critical supplier to the global aquafeed, poultry feed, and pet food sectors. Its core operations involve processing raw fish into nutrient-dense protein sources and essential fatty acids, including Omega-3. The product portfolio includes steam-dried fish meal and high-grade fish oil used in specialized animal nutrition formulations. Mukka Proteins maintains a robust supply chain and utilizes advanced processing technologies to ensure product consistency and nutritional integrity. The company caters to both domestic and international markets, positioning itself as a key provider of sustainable marine protein ingredients for the livestock and aquaculture sectors.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice regarding the 01/2024 Extra-Ordinary General Meeting (EGM) of Mukka Proteins Limited, including details about the meeting date, e-voting procedures, and compliance with regulatory circulars. It is a formal announcement informing shareholders about the upcoming EGM and voting arrangements, without containing financial statements or detailed financial analysis. The document also includes references to regulatory compliance and voting rights but does not present the results of the voting or the meeting itself. Therefore, this document is best classified as a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2024-10-24 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice of an Extra-Ordinary General Meeting (EGM) scheduled for November 16, 2024. It includes the agenda items such as approval for increase in authorised share capital and approval for raising funds through issuance of equity shares via preferential issue. The document references regulatory compliance with SEBI Listing Obligations and Disclosure Requirements, Companies Act provisions, and other regulatory authorities. It is a formal meeting notice sent to shareholders, containing resolutions to be voted on at the EGM. There are no financial statements or management discussion and analysis included, nor is it a transcript or report of the meeting outcomes. The document is not a report publication announcement since it contains the full notice text and detailed resolutions. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings such as EGMs.
2024-10-23 English
Outcome of Board Meeting
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding a rectification of a typographical error in the outcome of a Board Meeting dated October 21, 2024. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events including board meeting outcomes. The content focuses on correcting previously submitted information about investors and share allotments from a board meeting outcome. There is no detailed financial data or comprehensive report content, but rather a correction notice related to a board meeting outcome announcement. This fits the category of a Regulatory Filing (RNS) as it is a compliance disclosure correcting a prior filing and does not constitute a full report or financial statement.
2024-10-22 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a detailed notice regarding an Extra-Ordinary General Meeting (EGM) scheduled for November 16, 2024, including information about e-voting and participation through video conferencing. It references compliance with SEBI regulations and Ministry of Corporate Affairs circulars. The document includes a newspaper advertisement notice and detailed procedural information for shareholders about the EGM. There is no financial data, earnings information, or audit content. It is not a proxy solicitation or voting results announcement but rather an informational notice about the upcoming EGM and e-voting process. Therefore, it fits best under the category of Regulatory Filings (RNS), as it is a regulatory announcement about the meeting and voting process, not the meeting materials themselves or voting results.
2024-10-22 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding a fine levied for delay in compliance with a regulatory requirement related to the appointment or continuation of a non-executive director over the age of seventy-five. It discusses the board's comments on the fine and the company's assurance to comply going forward. The document is a communication about a regulatory compliance issue and board commentary, not a full report or financial statement. It does not contain financial data or detailed management discussion, nor is it a voting result or a capital change announcement. It fits best as a Regulatory Filing (RNS) because it is a regulatory announcement related to compliance and board commentary without constituting a formal report or financial filing.
2024-10-22 English
Increase in Authorised Capital
Capital/Financing Update Classification · 95% confidence The document is a formal announcement from the Board of Directors of Mukka Proteins Limited regarding the approval of an increase in authorized share capital and a preferential issue of equity shares. It includes detailed disclosures about the preferential allotment, the number of shares to be issued, the issue price, and the names of the investors. The document also mentions the scheduling of an Extra-Ordinary General Meeting for shareholder approval. The content focuses on capital structure changes and fundraising activities through share issuance. There are no financial statements or comprehensive financial performance data, so it is not an Annual Report or Interim Report. It is not a voting result declaration or a management report. The document fits the definition of a Capital/Financing Update as it provides updates on company fundraising and capital structure changes.
2024-10-21 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.